Similar articles

• Beta-blockers in the prevention of myocardial infarction.

  Hampton JR. Hampton JR. Practitioner. 1984 Jan;228(1387):55-63. Practitioner. 1984. PMID: 6141556 Clinical Trial. No abstract available.
• The role of pharmacotherapy in secondary prevention of myocardial infarction and death.

  Gorlin R, Fuster V. Gorlin R, et al. Mt Sinai J Med. 1984 Jun;51(3):229-36. Mt Sinai J Med. 1984. PMID: 6146929 Clinical Trial. No abstract available.
• [Secondary prevention of myocardial infarct using beta-blockers].

  Vacheron A. Vacheron A. Bull Acad Natl Med. 1985 Mar;169(3):369-73. Bull Acad Natl Med. 1985. PMID: 2864119 Clinical Trial. French. No abstract available.
• Beta-blocker underuse in secondary prevention of myocardial infarction.

  Everly MJ, Heaton PC, Cluxton RJ Jr. Everly MJ, et al. Ann Pharmacother. 2004 Feb;38(2):286-93. doi: 10.1345/aph.1C472. Epub 2003 Dec 30. Ann Pharmacother. 2004. PMID: 14742768 Review.
• Secondary prevention after myocardial infarction: facts and fallacies.

  Taylor SH. Taylor SH. J Cardiovasc Pharmacol. 1984;6 Suppl 6:S914-21. J Cardiovasc Pharmacol. 1984. PMID: 6084149 Review.